News
Myriad Genetics Says US Patent And Trademark Office Has Granted Patent That Covers Use Of Push-Button Blood Collection Devices For PCR-Based Fetal Sex Determination
20 Mar 24
News
Myriad Genetics: Q4 Earnings Insights
27 Feb 24
Earnings
Myriad Genetics Q4 2023 Adj EPS $0.04 Beats $0.01 Estimate, Sales $196.60M Beat $194.78M Estimate
27 Feb 24
Earnings, Earnings Beats, News
Myriad Genetics And National Cancer Center Hospital East In Japan Collaborate On Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
27 Feb 24
Biotech, News, Global, General
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Myriad Genetics Earnings Preview
26 Feb 24
Earnings
Goldman Sachs Maintains Buy on Myriad Genetics, Raises Price Target to $31
30 Jan 24
News, Price Target, Analyst Ratings
Press releases
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
16 Apr 24
Health Care, Press Releases
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
21 Mar 24
News, Health Care, Legal, Press Releases
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
20 Mar 24
News, Legal, Press Releases
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
27 Feb 24
Health Care, Press Releases
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
1 Feb 24
M&A, News, Press Releases
Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology
30 Jan 24
News, Management, Press Releases